Androgen receptor antigen density and S-phase fraction in prostate cancer: a pilot study-Reference-Cited by-同舟云学术

Androgen receptor antigen density and S-phase fraction in prostate cancer: a pilot study

Published:2003-12 Issue:4 Volume:6 Page:294-300
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Abdel-Wahab M,Krishan A,Milikowski C,Wahab A A,Walker G,Markoe A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/4500672.pdf

Reference43 articles.

1. Jenster G et al. Domains of the human androgen receptor involved in steroid binding, transcriptional activity and subcellular localization. Mol Endocrinol 1991; 5: 1396–1404.

2. Klocker H et al. Androgen receptor mutations in prostate cancer. In: Wirth M, Altwein JE, Schmitz-Drager B, Kuptz S (eds). Molecular Biology of Prostate Cancer. Walter de Gruyter, New York, 1998, pp 81–88.

3. Kazemi-Esfarjani P, Trifiro MA, Pinksy L . Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the CAG expanded neuronopathies. Hum Mol Genet 1995; 4: 523–527.

4. Suzuki H . Androgen receptor gene mutations in human prostate cancer. J Steroid Biochem Mol Biol 1993; 46: 759–765.

5. Suzuki H et al. Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome. Prostate 1996; 29: 153–161.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells;Scientific Reports;2016-10-05

2. Radiolabeled 5-Iodo-3′-O-(17β-succinyl-5α-androstan-3-one)-2′-deoxyuridine and Its 5′-Monophosphate for Imaging and Therapy of Androgen Receptor-Positive Cancers: Synthesis and Biological Evaluation;Journal of Medicinal Chemistry;2009-08-04